Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Episode 34: Savolitinib in Renal Papillary Cancer - A Major Breakthrough?

    Episode 34: Savolitinib in Renal Papillary Cancer - A Major Breakthrough?

    FromThe Uromigos

    Start listeningView podcast show

    Episode 34: Savolitinib in Renal Papillary Cancer - A Major Breakthrough?

    FromThe Uromigos

    ratings:
    Length:
    21 minutes
    Released:
    May 30, 2020
    Format:
    Podcast episode

    Description

    Dr. Toni Choueiri discusses the results of this study, which appears to show a survival signal, but it is difficult to interpret. 
    Released:
    May 30, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    Broadcasting the latest developments in GU cancer